Cologne, Germany

Heino Staβ

This inventor holds 1 USPTO granted patent. Top assignee: Bayer Schering Pharma Ag. Active years: 2010.


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Heino Staβ: Innovator in Quinolone Antibiotics

Introduction

Heino Staβ is a notable inventor based in Kö'ln, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibiotic preparations. His work focuses on enhancing the efficacy and delivery of quinolone antibiotics.

Latest Patents

Heino Staβ holds a patent for "Sustained-release preparations of quinolone antibiotics and method for preparation thereof." This invention relates to an orally administrable preparation that comprises a quinolone antibiotic, which releases the active compound with a delay. This innovative approach aims to improve the therapeutic outcomes of antibiotic treatments.

Career Highlights

Heino Staβ is associated with Bayer Schering Pharma AG, a leading global pharmaceutical company. His role at Bayer has allowed him to contribute to the advancement of medical science through his research and inventions. His expertise in pharmaceutical formulations has been instrumental in developing new treatment options.

Collaborations

Heino Staβ has collaborated with notable colleagues, including Venkata-Rangarao Kanikanti and Roland Rupp. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Heino Staβ's contributions to the field of quinolone antibiotics exemplify the impact of innovative thinking in pharmaceuticals. His patent and work at Bayer Schering Pharma AG highlight the importance of sustained-release formulations in improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…